Concepedia

William Z. Potter

WZ

Statistics

Publications

48

Citations

4.1K

H-Index

28

Active since

1974

Affiliations

National Institute of Mental Health(Current)

National Institutes of Health

Eli Lilly (United States)

National Heart Lung and Blood Institute

Merck & Co., Inc., Rahway, NJ, USA (United States)

William Z. Potter is an author at National Institute of Mental Health specializing in medicine, pharmacology, and psychiatry.

ORCID

Top concepts

Publications per year

1974–2025

48

Publications

48

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Anantha Shekhar, William Z. Potter, Jeffrey Lightfoot et al. · American Journal of Psychiatry · 2008 · 555 citations

Acetaminophen‐induced hepatic injury: Protective role of glutathione in man and rationale for therapy

Jerry R. Mitchell, Snorri S. Thorgeirsson, William Z. Potter et al. · Clinical Pharmacology & Therapeutics · 1974 · 531 citations

, , +18

Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Thomas Spencer, John H. Heiligenstein, Joseph Biederman et al. · The Journal of Clinical Psychiatry · 2002 · 336 citations

Acetaminophen-Induced Hepatic Necrosis V. Correlation of Hepatic Necrosis, Covalent Binding and Glutathione Depletion in Hamsters

William Z. Potter, S.S. Thorgeirsson, David J. Jollow et al. · Pharmacology · 1974 · 303 citations

, , +20

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

Jerry R. Mitchell, Unnur P. Thorgeirsson, Martin Black et al. · Clinical Pharmacology & Therapeutics · 1975 · 302 citations

1–5 of 48